脱细胞生物肌肉筋膜腹壁支架移植物的实验研究
本研究开发了一种新型脱细胞方法,用于猪肌肉筋膜以模拟目标组织结构,并分析其机械强度与组织整合。结果显示该支架无DNA残留,机械强度与商用生物补片AlloDerm相当,且在大鼠皮下植入后无排斥,可见渐进性胶原沉积和新生血管形成。
要点
- 脱细胞肌肉筋膜支架无DNA残留,机械强度与AlloDerm相当。
- 大鼠皮下植入无排斥,可见胶原沉积和新生血管。
- 该支架结合肌肉的血管生成能力和筋膜的强度。
核心结论
- 脱细胞方法可成功制备无DNA的复合腹壁肌肉筋膜支架,可在同种内植入无排斥。
- 该支架兼具脱细胞肌肉的血管生成能力和脱细胞筋膜的固有强度。
研究设计与样本
- 研究对猪肌肉筋膜进行序列脱细胞处理制成补片,检测机械强度和DNA含量。
- 将肌肉筋膜补片植入大鼠皮下(每组n=4),分别于1至4周后处死,进行组织学或免疫组化检查。
主要发现
- 机械测试显示与商用生物补片AlloDerm强度相当,机械强度归因于筋膜成分。
- 移植物成功植入,无可见不良事件,大体坏死检查显示良好的皮下支架植入。
- 显微镜评估发现移植物内渐进性胶原沉积、新生血管形成和CD34阳性细胞存在,无明显移植物排斥。
临床怎么用
- 该脱细胞肌肉筋膜支架可能作为复杂腹壁重建的生物补片选择,但需进一步临床前体内强度分析。
局限性
- 研究仅在大鼠皮下模型中进行,样本量小(每组n=4),未评估长期效果和临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complex abdominal wall reconstruction using biologic mesh can lead to increased recurrence rates, nonincorporation, and high perioperative costs. We developed a novel decellularization method and applied it to porcine muscle fascia to mirror target-tissue architecture. The aims of this study were to analyze mechanical strength and tissue-graft incorporation. METHODS: After serial decellularization, muscle-fascia mesh was created and tested for mechanical strength and DNA content. The muscle-fascia mesh was implanted subcutaneously in rats (n = 4/group) and the cohorts killed 1 to 4 weeks later. Explants were examined histologically or immunohistochemically. RESULTS: Mechanical testing demonstrated equivalent strength compared with a commercially available biological mesh (AlloDerm), with mechanical strength attributable to the fascia component. Grafts were successfully implanted with no observable adverse events. Gross necroscopy revealed excellent subdermal scaffold engraftment. Microscopic evaluation identified progressive collagen deposition within the graft, neoangiogenesis, and presence of CD34 positive cells, in the absence of discernable graft rejection. CONCLUSION: This study confirms a decellularization process can successfully create a DNA-free composite abdominal wall (muscle-fascia) scaffold that can be implanted intraspecies without rejection. Expanding this approach may allow exploitation of the angiogenic capacities of decellularized muscle, concomitant with the inherent strength of decellularized fascia, to perform preclinical analyses of graft strength in animal models in vivo.
引用
- Buell JF, Helm J, Mckillop IH, et al. Decellularized biologic muscle-fascia abdominal wall scaffold graft. Surgery. 2021. PMID: 33454133. doi:10.1016/j.surg.2020.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。